Kevin Davies

About

I've spent >30 years in science publishing as an editor of leading academic journals (with Nature Genetics, Nature and Cell Press); in trade publishing (Bio-IT World), and as a publisher (C&EN). In 2018 I spearheaded the launch of The CRISPR Journal, published by Mary Ann Liebert Inc. followed by GEN Biotechnology in 2022. My books include "The $1,000 Genome"​ (Free Press, 2010), "Cracking the Genome" (Free Press, 2001), and "Breakthrough: The Race for the Breast Cancer Gene." I'm co-author with Jim Watson and Andrew Berry of "DNA: The Story of the Genetic Revolution" (Knopf, 2017). Supported by a Guggenheim Fellowship, I published EDITING HUMANITY: The CRISPR Revolution and the New Era of Genome Editing, in October 2020, on the eve of the Nobel Prize for CRISPR (Pegasus Books. 2020). The book is being published in several countries including Japan, China, South Korea, Italy and Russia. (I'm also the narrator of the audiobook.) My next book is CURVED AIR -- a biography of sickle-cell disease, to be published by Harvard University Press. I'm the founding editor of Nature Genetics, the first journal spin-off from Nature. I hold an undergraduate degree in Biochemistry from Oxford University, a PhD in molecular genetics from the University of London, and did a couple of uneventful postdocs at MIT and Harvard Medical School before joining Nature.